文献速递血栓与止血

2011至2019年美国老年成人静脉血栓栓塞症死亡率及其趋势

Venous thromboembolism mortality and trends in older US adults, 2011-2019.
PubMed 文献 · Am J Hematol · 2023-06-27

基于2011-2019年Medicare 20%样本,分析65岁以上美国成人新发静脉血栓栓塞症(VTE)后30天和1年全因死亡风险及趋势。VTE后30天死亡风险3.1%(95%CI 3.0-3.2),1年19.6%(95%CI 19.2-20.1);癌症相关VTE年龄-性别-种族标准化30天风险6.0%、1年34.7%。非白人和低社会经济地位者标准化风险更高,1年死亡风险平均每年下降0.28个百分点(95%CI 0.16-0.40),30天死亡风险无趋势。

要点

  • 老年VTE后30天全因死亡风险3.1%(95%CI 3.0-3.2),1年19.6%(95%CI 19.2-20.1)。
  • 癌症相关VTE年龄-性别-种族标准化30天风险6.0%,1年34.7%。
  • 非白人和低社会经济地位者标准化30天及1年风险更高。

核心结论

  • 过去十年新发VTE后全因死亡风险略有下降,但种族和社会经济差异持续存在。
  • 理解人口学亚组和癌症相关事件的死亡模式对针对性改善VTE管理重要。

研究设计与样本

  • 从2011-2019年Medicare 20%样本中识别新发VTE病例,该样本代表几乎所有65岁及以上美国人。
  • 社会剥夺指数从公共数据链接;种族/民族和性别为自我报告。
  • 采用基于模型的标准化计算人口学亚组和按现患癌症诊断状态分层的VTE后30天和1年全因死亡风险。

主要发现

  • 老年美国成人新发VTE后全因死亡风险30天为3.1%(95%CI 3.0-3.2),1年为19.6%(95%CI 19.2-20.1)。
  • 癌症相关VTE事件的年龄-性别-种族标准化风险30天为6.0%,1年为34.7%。
  • 非白人受益者和低社会经济地位者标准化30天及1年风险更高。
  • 研究期间1年死亡风险平均每年下降0.28个百分点(95%CI 0.16-0.40),30天死亡风险无趋势。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Venous thromboembolism (VTE) affects 1.2 million people per year in the United States. With several clinical changes in diagnosis and treatment approaches in the past decade, we evaluated contemporary post-VTE mortality risk profiles and trends. Incident VTE cases were identified from the 2011-2019 Medicare 20% Sample, which is representative of nearly all Americans aged 65 and older. The social deprivation index was linked from public data; race/ethnicity and sex were self-reported. The all-cause mortality risk 30 days and 1 year after incident VTE was calculated in demographic subgroups and by prevalent cancer diagnosis status using model-based standardization. Risks for major cancer types, risk differences by age, sex, race/ethnicity, and socio-economic status (SES), and trends over time are also reported. The all-cause mortality risk among older US adults following incident VTE was 3.1% (95% CI 3.0-3.2) at 30 days and 19.6% (95% CI 19.2-20.1) at 1 year. For cancer-related VTE events, the age-sex-race-standardized risk was 6.0% at 30 days and 34.7% at 1 year. The standardized 30-day and 1-year risks were higher among non-White beneficiaries and among those with low SES. One-year mortality risk decreased 0.28 percentage points per year (95% CI 0.16-0.40) on average across the study period, with no trend observed for 30-day mortality risk. In sum, all-cause mortality risk following incident VTE has decreased slightly in the last decade, but racial and socio-economic disparities persist. Understanding patterns of mortality among demographic subgroups and in cancer-associated events is important for targeting efforts to improve VTE management.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Giorgio K, Walker RF, MacLehose RF, et al. Venous thromboembolism mortality and trends in older US adults, 2011-2019. Am J Hematol. 2023. PMID: 37366276. doi:10.1002/ajh.26996

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。